34 |
Klinisk Biokemi i Norden · 3 2013
Referenser
1. Hillarp A, Dahlbäck B, Strandberg K. Lau-
rells Klinisk kemi i praktisk medicin 2012.
Koagulationsrubbningar; 181-209. Redaktion
Nilsson-Ehle P. Berggren-Söderlund M. Theo-
dorsson E.
2. Kjellberg M, Ikonomou T, Stenflo J. The clea-
ved and latent forms of antithrombin are nor-
mal constituents of blood plasma: a quantita-
tive method to measure cleaved antithrombin.
J Thromb Haemost 2006;4:168-76.
3. Hemker CH. Thrombin generation in whole
blood. Br J Haematol 2008;141:895–908.
4. Stenflo J. A new vitamin K-dependent protein.
J Biol Chem 1976;251:355-63.
5. Stenflo J. En resa med Protein C – ett nytt
K-vitaminberoende protein. Klinisk Biokemi
i Norden 2012;25:32-40.
6. Gruber A, Griffin JH. Direct detection of
activated Protein C in blood from human
subjects. Blood 1992;79:2340-8.
7. Dahlbäck B. Advances in understanding pat-
hogenic mechanisms of thrombophilic disor-
ders. Blood. 2008; 112: 19-27.
8. Dahlbäck B, Villoutreix BO. The anticoagulant
protein C pathway. FEBS Lett 2005;579:3310-
6.
9. Esmon CT, Owen WG. Identification of an
endothelial cell cofactor for thrombin-cata-
lyzed activation of Protein C. Proc Natl Acad
SCI USA 1981;78:2249-53.
10. Dahlbäck B, Carlsson M, Svensson PJ. Fami-
lial thrombophilia due to a previously unre-
cognized mechanism characterized by poor
anticoagulant response to activated protein C:
Prediction of a cofactor to activated protein C.
Proc Natl Acad Sci USA 1993;90:1004-8.
11. Huntington J, Kjellberg M, Stenflo, J. Crys-
tal structure of Protein C inhibitor provides
insight into hormone binding and heparin
activation. Structure 2003;11:205-15.
12. Strandberg K, Kjellberg M, Erb E-M, Pers-
son U, Mosher DF, Villoutreix BO. Stenflo
J. Activated Protein C-Protein C Inhibitor
complex formation: characterization of a
neoepitope provides evidence for extensive
insertion of the reactive center loop. Bio-
chemistry 2000;39:15713-20.
13. Strandberg K, Kjellberg M, Knebel R, Lilja
H, Stenflo J. A sensitive immunochemical
assay for measuring the concentration of
the activated Protein C-Protein C inhibi-
tor complex in plasma. Thromb Haemost
2001;86:604-10.
14. Edler I, Hertz CH. The early work of ultra-
sound in medicine at the University of Lund.
J Clin Ultrasound 1977;5:352-6.
15. Kölbel T, Strandberg K, Mattiasson I, Sten-
flo J, Lindblad B. Activated Protein C-Pro-
tein C inhibitor complex: A new biological
marker for aortic aneurysms. J Vasc Surg
2006;43:935-9.
16. Stenflo J, Kjellberg M, Strandberg K, Svens-
son PJ, Kölbel T, Lindblad B. The complex
between activated Protein C and Protein
C inhibitor: A clinically useful indicator
of aortic aneurysms? Blood Cells Mol Dis
2006;36:118-21.
17. Kölbel T, Strandberg K, Donath T, Mattiasson
I, Stenflo J, Lindblad B. Activated Protein C–
Protein C inhibitor complex in patients with
abdominal aortic aneurysms: Is it associated
with diameter and growth rate? Vasc Endo-
vascular Surg 2008;42:135-40.
18. Van Vlijmen EF, Brouwer JL, Veeger NJ,
Eskes TK, De Graeff PA, Van der Meer J.
Oral contraceptives and the absolute risk of
venous thromboembolism in women with
Fotnoter
1
Huntington JA, Read RJ, Carrell, RW. Structure of a serpin-protease complex shows inhibition by deformation. Nature
407;2000;923-6.
2
Huntington J., Kjellberg M, Stenflo, J. Crystal structure of Protein C inhibitor provides insight into hormone binding and
heparin activation. Structure 2003;11:205-15.
3
Strandberg K, Kjellberg M, Erb E-M, Persson U, Mosher D, Villoutreix BO, Stenflo J. Activated Protein C-Protein C inhibitor
complex formation: Characterization of a neoepitope provides evidence for extensive insertion of the reactive center loop.
Biochemistry 2000;39:15713-29.
